Fungal infections in iatrogenically compromised hosts

Adv Intern Med. 1998;43:321-71.
No abstract available

Publication types

  • Review

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis*
  • Aspergillosis / drug therapy
  • Aspergillosis / prevention & control
  • Aspergillosis / surgery
  • Azoles / therapeutic use
  • Candidiasis / diagnosis*
  • Candidiasis / drug therapy
  • Candidiasis / prevention & control
  • Catheters, Indwelling / adverse effects
  • Diagnosis, Differential
  • Flucytosine / therapeutic use
  • Fusarium
  • Humans
  • Iatrogenic Disease*
  • Immunocompromised Host*
  • Mycoses / diagnosis
  • Mycoses / drug therapy
  • Opportunistic Infections / diagnosis*
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / prevention & control
  • Opportunistic Infections / surgery
  • Syndrome
  • Trichosporon

Substances

  • Antifungal Agents
  • Azoles
  • Amphotericin B
  • Flucytosine